Viewing Study NCT04843761


Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2026-03-19 @ 9:29 PM
Study NCT ID: NCT04843761
Status: COMPLETED
Last Update Posted: 2025-10-24
First Post: 2021-04-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-20
Start Date Type: ACTUAL
Primary Completion Date: 2022-08-22
Primary Completion Date Type: ACTUAL
Completion Date: 2022-11-20
Completion Date Type: ACTUAL
First Submit Date: 2021-04-09
First Submit QC Date: None
Study First Post Date: 2021-04-14
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-05-22
Results First Submit QC Date: None
Results First Post Date: 2025-10-24
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-09
Last Update Post Date: 2025-10-24
Last Update Post Date Type: ESTIMATED